Skip to content

Addiction: all studies

Page 415 of 863: studies 4,141 to 4,150 of 8,627, newest first. Back to the addiction overview

Research

The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey

Medicina May 9, 2023 Gniewko Więckiewicz, Julia Marek, Iga Stokłosa et al. 5 citations

Background and Objectives: PolDrugs is the largest Polish naturalistic nationwide survey to present basic demographic and epidemiological data that could potentially prevent harm from illicit substances intake in drugs users. The most recent results were presented in 2021. The goal of this year’s edition was to re-present the above data and compare it to the previous edition’s data to identify...

Psychotogenic potential of prescribed drugs

Australian & New Zealand Journal of Psychiatry May 6, 2023 Julia Lappin, Shane Darke, Michael Farrell

Australian & New Zealand Journal of Psychiatry, 57(6) Interest in prescribing psychoactive drugs as treatments for mental health conditions has been highlighted recently by the decision by the Therapeutic Goods Administration (TGA) to permit, from 1 July 2023, authorised psychiatrists to prescribe medicines containing psilocybin for treatment-resistant depression and...

NMA/AGSM/2022/BCS/009 - Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Geraniol, Acyclic Isoprenoid Monoterpene in Ketamine-Induced Psychosis in Mice

Nigerian Medical Journal May 5, 2023 C. Uruaka, O. Georgewill, OU Georgewill

Background Schizophrenia is a chronic neuropsychiatric disease characterized by neurochemical, neurotrophic, and oxido-inflammatory derangements. Geraniol is a neuroactive acyclic isoprenoid monoterpene, which has been reported to demonstrate depressant and antioxidant/anti-inflammatory activities. Herein, we investigated whether geraniol could prevent or reverse ketamine-induced...

The phenomenology of auditory verbal hallucinations among clients with schizophrenia: The association with acceptance and autonomous action responses.

Archives of Psychiatric Nursing May 5, 2023 Ayman Mohamed El-Ashry, Eman Sameh Abd Elhay, Mona Metwally El-Sayed

Background: Living with the experience of hearing voices without trying to ignore or suppress them is referred to as accepting auditory verbal hallucinations (AVH). It varies depending on the phenomenology of AVH itself; some clients may find it challenging to acquire new coping mechanisms with the voices. Aim: Examine the association between the phenomenology of AVH and acceptance or...

On the application of Machine Learning and Complex Networks to Neuroscience

May 5, 2023 Caroline L. Alves

Data mining and knowledge discovery is a research area with applications in various fields, such as medicine. Data mining methods have proven to be very effective in making automated diagnoses and help medical teams in decision making. In addition to using data mining, medical data can be represented by complex networks. In the case of the brain, for example, brain regions can be represented as...

Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study

European Neuropsychopharmacology May 4, 2023 Stefania Chiappini, Giacomo D’andrea, Sergio De Filippis et al. 48 citations

Esketamine, the S-enantiomer of ketamine, has recently emerged as a therapy for treatment-resistant depression (TRD), showing both rapid antidepressant action and good efficacy and high safety. It is also indicated for the acute short-term treatment of psychiatric emergency due to major depressive disorder (MDD) and for depressive symptoms in adults with MDD with acute suicidal...

Nitrous oxide: a unique official French addictovigilance national survey

Frontiers in Public Health May 3, 2023 M. Guerlais, Aurélie Aquizerate, A. Lionnet et al.

Introduction Nitrous oxide has become over the last few years a public health problem in many countries. France has a dedicated health monitoring system dedicated to the surveillance of the abuse, dependence and consequences associated with the use of psychoactive substances coordinated by the French National Agency for the Safety of Medicines and Health Products. We present the French national...

Age-related learning difficulty through trial-and-error method associated with decreased default mode network integration in healthy middle-aged adults.

Journal of Clinical and Experimental Neuropsychology May 2023 Madoka Yamashita, Tetsuya Shimokawa, Rumi Tanemura

Efficient learning is critical to adapting to different environments. There are well-known learning principles in cognitive rehabilitation, including errorless (EL) and trial-and-error (T&E) learning; however, little is known about their underlying neural mechanisms. In the current study, to understand the age-related changes in learning benefits and neural mechanisms applying EL and T&E...

The Relationship between Mindfulness and Readiness to Change in Alcohol Drinkers

International Journal of Environmental Research and Public Health May 1, 2023 Eid Abo Hamza, Adam Yoon, Liquan Liu et al. 6 citations

Mindfulness is a multi-faceted construct that involves paying attention to thoughts and emotions without automatically reacting and being critical of them. Recent research has suggested that mindfulness might play an important role in reducing problematic alcohol use. Further, Readiness to Change (RTC) is related to motivation to change drinking behaviours. The RTC scale identifies motivation...

Phencyclidine Disrupts Neural Coordination and Cognitive Control by Dysregulating Translation

Biological Psychiatry Global Open Science May 1, 2023 Eunhye Park, Hsin-Yi Kao, Hussam Jourdi et al.

Background Phencyclidine (PCP) causes psychosis, is abused with increasing frequency, and was extensively used in antipsychotic drug discovery. PCP discoordinates hippocampal ensemble action potential discharge and impairs cognitive control in rats, but how this uncompetitive NMDA receptor (NMDAR) antagonist impairs cognition remains unknown. Methods The effects of PCP were investigated on...